By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is overwhelmingly bearish on ARM's current valuation, with key concerns being execution risk, potential cannibalization of licensing revenue, and geopolitical risks, particularly around China.
Risk: Geopolitical risks, particularly around China, which accounts for roughly 20-25% of ARM's revenue.
Opportunity: None identified.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Arm Holdings plc (NASDAQ:ARM) was among the stocks Jim Cramer discussed in this changing market. Cramer highlighted the stock’s growth after he purchased it for the Charitable Trust, as he commented:
Same goes for Arm Holdings. The chip design company had been putting up some pretty good numbers. But more important, it announced that rather than just licensing its technology to other chip makers, Arm would also make their own CPUs, big change, right when we started hearing that these new AI agents needed a ton of advanced CPUs to operate. It’s a windfall for anyone who can make CPUs, meaning Intel, AMD, and Arm Holdings. I don’t know, Arm’s trading at 172… Been at 115 just a couple weeks ago when I learned this…. I had passed on almost 60 points.
So what did I say? I said, well, I’m too late. But you know what? I couldn’t resist the temptation. CEO Rene Haas was so… bullish in our interview from the NVIDIA GTC conference, and he’s always been straight. I’d already missed Intel. I’d passed on AMD, so I decided enough is enough. Just forget where the… thing came from and do some buying. Sure enough, as people realized that we’re going to need more CPUs in the data center, Arm, at $172 when I purchased it, proceeded to roar right to $302.
Stock market data. Photo by Burak The Weekender on Pexels
Arm Holdings plc (NASDAQ:ARM) designs and licenses CPU architectures, system IP, and software used across automotive, computing, consumer, and IoT applications.
While we acknowledge the potential of ARM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"ARM has already captured AI-driven re-rating; further gains require execution risk that isn't priced in, but downside from $302 is material if Q2-Q3 guidance disappoints on data center traction."
Cramer's ARM trade is a textbook case of FOMO-driven momentum buying, not fundamental analysis. He admits ignoring price history ($115→$172→$302), then frames it as conviction based on a CEO interview. The real story: ARM announced CPU manufacturing ambitions, which is strategically sound, but the stock has already priced in aggressive AI upside. At $302, ARM trades ~60x forward earnings with single-digit revenue growth expected through 2025. The article itself undermines its own thesis by immediately pivoting to 'other AI stocks offer greater upside'—a red flag that even the author sees valuation risk.
ARM's architectural moat in mobile/IoT is genuine, and data center CPU demand is real. If the company executes manufacturing partnerships faster than expected and captures even 5-10% of incremental AI inference workloads, current valuation could compress multiples rather than expand—meaning downside is capped by fundamentals, not just sentiment.
"The article's momentum story masks valuation and business-model vulnerabilities that could cap further upside even if AI CPU demand holds."
Cramer's ARM purchase at 172, riding AI-driven CPU demand to 302, frames the stock as a late-entry winner after missing Intel and AMD. Yet the narrative skips ARM's core licensing model risks, limited control over manufacturing, and already-elevated multiples that priced in aggressive growth. The pivot toward proprietary CPUs introduces new competitive and execution variables against entrenched players. Broader AI capex sustainability and potential share gains by custom silicon from hyperscalers remain unexamined, making the win look more momentum-driven than structurally durable.
ARM's design wins in data-center CPUs have accelerated faster than modeled, with licensing royalties potentially compounding if the own-CPU effort validates demand without cannibalizing existing partners.
"ARM's current valuation reflects an unrealistic expectation that it can successfully pivot to hardware manufacturing without eroding its core high-margin IP licensing business."
Cramer’s narrative on ARM ignores the fundamental shift in its business model from a pure-play royalty collector to a potential hardware competitor. While the stock has seen massive momentum, the valuation is now detached from its historical licensing-based earnings multiples. Trading at over 100x forward P/E (price-to-earnings ratio), ARM is priced for perfect execution in its new CPU initiatives. If Arm attempts to compete directly with its own licensees—like Qualcomm or Apple—it risks cannibalizing its core IP licensing revenue. The 'windfall' narrative assumes a seamless transition into hardware manufacturing, which is capital-intensive and historically lower-margin than their high-margin royalty business.
If Arm’s new Neoverse-based CPU designs become the industry standard for AI agents, they could capture a massive share of the data center spend, justifying a premium valuation as the 'picks and shovels' provider for the entire AI ecosystem.
"The article overstretches Arm's pivot to 'own CPUs'—Arm's core value remains IP licensing, and turning to manufacturing would require massive capex and could cannibalize its primary revenue model."
Arm's rally after a purported pivot to 'own CPUs' looks more narrative-driven than fundamentals-supported. Arm's moat has long been IP licensing; a shift to manufacturing would demand massive capex, new supply chains, and could cannibalize licensing revenue while straining licensee relationships (e.g., Apple, AWS). AI demand is real but not guaranteed to translate into Arm-dominated CPUs versus x86 incumbents and accelerators. The piece glosses over policy/macroeconomic risks (tariffs/onshoring) as if they guarantee gains. Absent a credible, monetizable pivot plan, near-term upside appears capped and the stock may be pricing in an outcome that isn’t assured.
But the bull case would argue Arm could monetize a selective manufacturing push through partnerships, potentially lifting margins if execution is disciplined.
"Cannibalization risk is overstated; execution timing risk is the actual valuation cliff."
Everyone's fixated on the CPU cannibalization risk, but nobody's quantified the actual threat. ARM's licensing revenue is ~$800M annually; even if CPUs capture 20% of data-center AI spend ($50B+ TAM), royalty erosion from existing licensees matters less than the absolute dollar upside. The real risk isn't cannibalization—it's execution delay. If partnerships slip 18 months, the 100x multiple evaporates regardless of moat strength.
"Licensee defection risk is binary and faster than any TAM upside calculation implies."
Claude's $800M licensing figure and 20% TAM capture math understates how quickly key licensees like Apple and AWS could accelerate custom silicon if ARM enters CPUs, turning royalty erosion binary rather than gradual. Execution slips matter, but the unexamined trigger is whether those same partners pre-emptively redesign around ARM to protect their own margins, shrinking the royalty base before any new CPU revenue arrives.
"The primary risk to ARM's valuation is geopolitical exposure in China rather than internal cannibalization of royalty revenue."
Grok, your 'binary royalty erosion' theory assumes ARM's licensees have viable alternatives. They don't. The x86 architecture is losing, not gaining, ground in power-efficient data centers. The true risk is not internal competition, but the 'China factor'—roughly 20-25% of ARM's revenue. If geopolitical friction or export controls tighten on ARM’s IP transfer to Chinese chipmakers, the valuation collapses regardless of CPU manufacturing success. That geopolitical tail risk is the elephant in the room.
"Regulatory/export-control risk, especially in China, could erode ARM's licensing moat and royalty base enough to compress multiples more than any near-term execution concerns."
Gemini, your China risk is real but under-weighted in probability-adjusted terms. Export-controls and onshoring could not only cap China revenue (~20-25%) but also disrupt ARM’s licensing ecosystem; if licenses become less portable or partners push in-house, royalty streams compress even before Neoverse yields material revenue. This regulatory knob could weight on the multiple more than execution slides, making risk-reward more skewed bearish than your scenario assumes. (speculative)
The panel consensus is overwhelmingly bearish on ARM's current valuation, with key concerns being execution risk, potential cannibalization of licensing revenue, and geopolitical risks, particularly around China.
None identified.
Geopolitical risks, particularly around China, which accounts for roughly 20-25% of ARM's revenue.